Edwards Lifesciences EW
Edwards Lifesciences is the 228th largest S&P 500 company by market cap, worth $51.3 billion. 9 directors have filed with the SEC in the last 12 months (who counts), 1 of them an executive. 7 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 12.2% of the company.
- CEO
- Bernard J. Zovighian
- Sector
- Health Care
- Sub-industry
- Health Care Equipment
- Headquarters
- Irvine, California
- Founded
- 1958
- More
- Wikipedia
- Market cap
- $51.3B
- 228th largest, 23 Oct 2026 close
- Price to sales
- 8.5
- Market cap over revenue
- Market cap per employee
- $3.2M
- Market cap over employees
- Connections
- 1
- S&P 500 companies sharing a director or officer
Largest institutional holders
Each fund group's share of Edwards Lifesciences. Where a company has several share classes, the share is of its total value.
13F filings for the quarter to 30 Jun 2026
Board and officers
1 person here also holds roles at other S&P 500 companies.
Roles filed up to 30 Sep 2026
| Name | Title |
|---|---|
| Directors (9) | |
| Bernard J. ZovighianCEO | |
| Leslie C. DavisDirector | |
| David T. FeinbergDirectorAlso at Humana | |
| Kieran GallahueDirector | |
| Paul A. LavioletteDirector | |
| Steven R. LorangerDirector | |
| Ramona SequeiraDirector | |
| Heisz Leslie StoneDirector | |
| Nicholas J. ValerianiDirector | |
| Officers (7) | |
| Theodora MistrasCVP, Chief Financial OfficerLast filed 10 Jul 2026 | |
| Donald E. Bobo Jr.CVP,Strategy/Corp DevelopmentLast filed 27 May 2026 | |
| Annette BrulsCvp, EmeaclaLast filed 28 Aug 2026 | |
| Daveen ChopraCVP, TMTT, Surgical & IHFMLast filed 11 Sep 2026 | |
| Andrew M. DahlSVP, Corporate ControllerLast filed 14 Sep 2026 | |
| Daniel J. LippisCvp, TavrLast filed 11 Sep 2026 | |
| Wayne MarkowitzCvp, JapacLast filed 14 Sep 2026 | |
Companies that share people with Edwards Lifesciences
Each person's title here, then at the other company.
- Humana HUM
- David T. Feinberg: Director here, Director there
Edwards Lifesciences' market cap since December 2008
Weekly, up to 23 Oct 2026
| Week ending | Market cap |
|---|---|
| 23 Oct 2026 | $51.3B |
| 26 Dec 2025 | $50.4B |
| 27 Dec 2024 | $44.6B |
| 29 Dec 2023 | $46.3B |
| 30 Dec 2022 | $46.1B |
| 31 Dec 2021 | $80.9B |
| 25 Dec 2020 | $55.2B |
| 27 Dec 2019 | $48.9B |
| 28 Dec 2018 | $31.4B |
| 29 Dec 2017 | $23.9B |
| 30 Dec 2016 | $20.0B |
| 25 Dec 2015 | $17.1B |
| 26 Dec 2014 | $13.9B |
| 27 Dec 2013 | $7.2B |
| 28 Dec 2012 | $10.3B |
| 30 Dec 2011 | $8.1B |
| 31 Dec 2010 | $9.2B |
| 25 Dec 2009 | $4.9B |
| 26 Dec 2008 | $3.0B |
Download Edwards Lifesciences' data as JSON, with the weekly market caps in billions of dollars from 5 Dec 2008.
Workforce
Headcount at 31 Dec 2025
- Employees
- 16,000
As of December 31, 2025, we had approximately 16,000 employees worldwide, the majority of whom were located in the United States, Singapore, and Costa Rica.
Insider trades
Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.
Trades from 30 Sep 2025 to 30 Sep 2026
Directors and officers sold $27.7 million of stock in 42 sales and made no open-market purchases in the 12 months to 30 Sep 2026.
| Date | Person | Value |
|---|---|---|
| 11 Sep 2026Sale | Daniel J. LippisCvp, Tavr | $54K |
| 31 Aug 2026Sale | Andrew M. DahlSVP, Corporate Controller | $50K |
| 28 Aug 2026Sale | Annette BrulsCvp, Emeacla | $238K |
| 26 Aug 2026Sale | Daveen ChopraCVP, TMTT, Surgical & IHFM | $2.9M |
| 26 Aug 2026Sale | Wayne MarkowitzCvp, Japac | $113K |
| 11 Aug 2026Sale | Daniel J. LippisCvp, Tavr | $57K |
| 30 Jul 2026Sale | Wayne MarkowitzCvp, Japac | $13K |
| 28 Jul 2026Sale | Wayne MarkowitzCvp, Japac | $819K |
| 27 Jul 2026Sale | Bernard J. ZovighianCEO | $245K |
| 10 Jul 2026Sale | Daniel J. LippisCvp, Tavr | $57K |
Showing 10 of 42 trades
Trades by members of Congress and officials
Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.
Trades from 20 Oct 2023 to 20 Oct 2026
10 people disclosed 9 purchases and 11 sales of Edwards Lifesciences stock since October 2023.
| Date | Member or official | Amount |
|---|---|---|
| 3 Aug 2026 | Rohit KhannaHouse, D-CA 路 Sold | $1K to $15K |
| 11 May 2026 | Donald J TrumpPresident 路 Bought | $50K to $100K |
| 13 Apr 2026 | Rohit KhannaHouse, D-CA 路 Bought | $1K to $15K |
| 10 Apr 2026 | Donald J TrumpPresident 路 Sold | $100K to $250K |
| 27 Mar 2026 | Alan ArmstrongSenate, R-OK 路 Bought | $1K to $15K |
| 10 Feb 2026 | Donald J TrumpPresident 路 Bought | $500K to $1M |
| 23 Jan 2026 | Rohit KhannaHouse, D-CA 路 Sold | $1K to $15K |
| 13 Jan 2026 | Rohit KhannaHouse, D-CA 路 Sold | $1K to $15K |
| 19 Nov 2025 | Josh GottheimerHouse, D-NJ 路 Sold | $1K to $15K |
| 7 Oct 2025 | Rohit KhannaHouse, D-CA 路 Sold | $1K to $15K |
Showing 10 of 20 trades
WARN layoff notices
Notices filed under Edwards Lifesciences' own name. Subsidiaries that file under their own names are not included.
Notices from 26 Oct 2023 to 26 Oct 2026
Edwards Lifesciences filed 2 notices covering 193 workers since October 2023.
| Notice | Place | Workers |
|---|---|---|
| 4 Sep 2024 | Irvine, CA | 192 |
| 4 Sep 2024 | Santa Ana, CA | 1 |